
Please try another search
BrightGene Bio-Medical Technology Co., Ltd., a pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China. The company offers Eribulin mesylate injection, Voriconazole for injection, Entecavir tablets, Oseltamivir phosphate capsule and dry suspension, Agatroban injection, Mikafungin sodium for injection, Fondaparinux sodium injection, and Caspofungin acetate for injection. It also provides antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, and other APIs and intermediates. In addition, the company offers veterinary drugs. BrightGene Bio-Medical Technology Co., Ltd. was founded in 2001 and is based in Suzhou, China.
Name | Age | Since | Title |
---|---|---|---|
Jiandong Yuan | 53 | - | Chairman & GM |
Ruyi He | 63 | 2023 | Independent Director |
Xing He | 42 | 2020 | Chairman of the Supervisory Board |
Lei Su | 37 | 2021 | Director |
Nan Ding | 34 | 2021 | Board Secretary & Director |
Yinghua Wu | 55 | 2023 | Independent Director |
Wei Cha | 55 | 2021 | Supervisor |
Yingxian Shen | 39 | 2017 | Supervisor |
Yuanlai Zou | 54 | 2015 | CFO & Director |
Dongdong Xu | 34 | 2023 | Independent Director |
Jingfu He | 40 | 2020 | Employee Representative Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review